Saturday 17 October 2026 Export PHAT’s income statement to Excel — free account

Phathom Pharmaceuticals, Inc.

Phathom Pharmaceuticals, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $175.1 million, up 216.9% from fiscal 2024. In the quarter to June 2026, revenue grew 88.0%, EPS grew 80.0%, free cash flow grew 96.9% and total debt fell 19.8%, each against the same quarter a year earlier.

6.92 0.58 −7.73%

Follow PHAT

Alert me

Market cap: $606.8M
P/E: 0.0×
Fwd P/E: −15.9×
Dividend yield: —
F-score: 4/9
Altman Z: −7.89
Beneish M: −1.39
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
ROE Full definition →	+8 more TTM periods Free account	90.07%	63.97%	46.58%	26.42%
ROA Full definition →		(87.53%)	(69.41%)	(52.49%)	(34.32%)
ROIC Full definition →		0.00%	0.00%	0.00%	0.00%
Return on Tangible Assets Full definition →		(237.06%)	(225.78%)	(103.12%)	(69.23%)
Average Days of Receivables Full definition →		138.34	162.85	143.80	148.37
Free Cash Flow per Share Full definition →		(3.07)	(2.29)	(1.19)	(0.44)
Free Cash Flow Full definition →		(225.38)	(167.00)	(97.76)	(36.91)
Capital Expenditures Full definition →		(0.15)	(0.23)	(0.27)	(0.22)
Other line items
Cash ROIC Full definition →		280.72%	168.50%	(1,282.32%)	(1,322.06%)
Accounts Receivable Turnover Full definition →		3.83	3.00	3.50	3.22
Accounts Payable Turnover Full definition →		4.57	2.92	3.43	8.74
Inventory Turnover Full definition →		5.58	5.18	6.38	7.35
Average Days of Payables Full definition →		20.91	80.48	75.26	47.81
Days of Inventory on Hand Full definition →		70.23	89.12	76.95	68.78
Tax Rate Full definition →		0.00	0.00	0.00	0.00
Research and Development Expense of Revenue Full definition →		23.01%	18.72%	15.31%	12.56%
Selling, General and Administrative Expense of Revenue Full definition →		209.27%	159.74%	116.77%	87.32%
Share Based Compensation of Revenue Full definition →		20.24%	16.40%	14.01%	11.33%
Interest Coverage Full definition →		(3.04)	(2.35)	(1.47)	(0.64)
Operating CF/Net income Full definition →		0.82	0.75	0.62	0.37
Depreciation/Fixed assets Full definition →		3.06	3.43	3.67	3.96
Capex/Depreciation Full definition →		(0.04)	(0.06)	(0.07)	(0.06)
Revenue per Share Full definition →		2.01	2.40	2.50	2.86
Operating CF per Share Full definition →		(3.07)	(2.29)	(1.19)	(0.44)
Capex per Share Full definition →		0.00	0.00	0.00	0.00
Capex to Sales Full definition →		0.00	0.00	0.00	0.00

Show all line items

Columns are period end dates

Stockrow Weekly